Join
Live feed
·
INSIDERFilingvia Quantisnow
Crescent Biopharma Inc. logo

SEC Form 4: USMAN NASSIM bought $3,139 worth of Common Stock (867 units at $3.62), increasing direct ownership by 5% to 18,041 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CBIO (Crescent Biopharma Inc.) and more on Quantisnow.